thejournalofprecisionmedicine.com

GENERAL
META
HTML
LINK ANALYSIS
SERVER
IP

Thejournalofprecisionmedicine.com receives any estimated 586 unique visitors and 31 unique page views per day. Revenue gained from these much visits may be $0 per day from various advertising sources. The estimated worth of site is $57. Similarweb global rank is 11,656,539. Maximum no. of users comes from .

Unified Layer is ISP, hosted on IP 162.144.102.124 in Country United States.

Website Age n/a
Alexa Rank no-data
Country United States
IP Address 162.144.102.124

META INFORMATION

Title

The Journal of Precision Medicine

Description

Keywords

Content Type

utf-8

No	Meta Name	Value
1	viewport	width=device-width, initial-scale=1
2	robots	index, follow

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 8.46 %

thejournalofprecisionmedicine.com has a website text/code ratio of 8.46 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

No	Text
1	Recent artıcles
2	Latest news
3	Multimedia
4	Tweets

No	Text
1	Latest issue
2	Genetic testing for heart diseases may help patients and families identify risks
3	Konica minolta precision medicine (kmpm) launches care for covıd program
4	Novartis announces phase ııı study of jakavi® in chronic graft-versus-host disease met primary and key secondary endpoints
5	European medicines agency validates bristol myers squibb’s application for car t cell therapy lisocabtagene maraleucel (liso-cel)
6	Thermo fisher scientific’s response to covıd-19 continues to expand to support development and production of therapeutics and vaccines
7	Multiple myeloma research foundation (mmrf) launches curecloud to democratize healthcare for cancer patients

Text Styling

STRONG0
B0
EM0
I0
U0
CITE0

LINK ANALYSIS

Total Link Count: 80

Internal Link Count : 65

No	Text	Type
1	Home	text
2	News	text
3	Archive	text
4	Events	text
5	Partners	text
6	Media	text
7	Videos	text
8	SUBSCRIBE	text
9	-	image
10	latest issue	text
11	Using Zebrafish to Advance Disease Research	text
12	Pioneering precision medicine in rheumatoid arthritis	text
13	Companion Diagnostics, Precision Medicine and Immuno-Oncology Therapies	text
14	Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities	text
15	COVID‑19 and pharmacogenomics: an a*ociation that warrants comprehensive a*essment	text
16	Lessons from oncology drive precision medicine across clinical specialties	text
17	A New Playbook for Cure-Seeking Nonprofits	text
18	Personalization and standardization: Can we have it all?	text
19	Personalized Medicine in the Aftermath of COVID-19	text
20	Focused On Precision Data	text
21	Diagnosing and Tracking COVID-19 Infections Leveraging Next-Gen Sequencing	text
22	Quick Take on Pharmacogenomics	text
23	The Burden of Proof – What Laboratories Need to Know About Evidence Development Before Launching a New Test	text
24	Expanding areas of impact for clinical diagnostics and precision medicine	text
25	How Cancer Patients Should Respond to the COVID-19 Pandemic	text
26	Quick Takes	text
27	The Journey to a COVID-19 Diagnostic Test	text
28	Clinical and real-world insights	text
29	The Licensing Conundrum	text
30	Why Standardizing the Use of Precision Medicine Should Be a Top Priority for Cancer Centers	text
31	Expert Feedback on Pain Points and Evolution in The Precision Medicine Landscape	text
32	-	image
33	Genetic testing for heart diseases may help patients and families identify risks	text
34	Read More	text
35	-	image
36	Konica Minolta Precision Medicine (KMPM) Launches Care for COVID Program	text
37	Read More	text
38	-	image
39	Novartis announces Phase III study of Jakavi® in chronic graft-versus-host disease met primary and key secondary endpoints	text
40	Read More	text
41	-	image
42	European Medicines Agency Validates Bristol Myers Squibb’s Application for CAR T Cell Therapy Lisocabtagene Maraleucel (liso-cel)	text
43	Read More	text
44	-	image
45	Thermo Fisher Scientific’s Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines	text
46	Read More	text
47	-	image
48	Multiple Myeloma Research Foundation (MMRF) Launches CureCloud to Democratize Healthcare for Cancer Patients	text
49	Read More	text
50	-	image

External Link Count : 15

No	Text	Type
1	The Journal of Precision Medicine Twitter	text
2	The Journal of Precision Medicine Linked In	text
3	-	image
4	-	image
5	-	image
6	-	image
7	-	image
8	@thermofisher	text
9	https://t.co/ts5tXnvpTa	text
10	https://t.co/tbSGJbUxcT	text
11	https://t.co/qAF0w4xtkw	text
12	https://t.co/eRErOAfMlL	text
13	-	image
14	SUBSCRIBE	text
15	-	image